NCT06421714View on ClinicalTrials.gov

A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 16, 2018

Primary Completion Date

October 14, 2018

Study Completion Date

October 14, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Venglustat

Pharmaceutical form:Capsule-Route of administration:Oral

DRUG

Itraconazole

Pharmaceutical form:Capsule-Route of administration:Oral

Trial Locations (1)

78744

PPD, Austin

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT06421714 - A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter